BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai KY, Yu YC, Leu YS, Chi CW, Chan ML, Tsai CH, Lin HC, Huang WC, Chen YJ. Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer. J Clin Med 2020;9:E387. [PMID: 32024132 DOI: 10.3390/jcm9020387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Xu C, Wang H, Song T, Wu S, Liang X, Xu H. Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma. Front Med (Lausanne) 2021;8:714619. [PMID: 34631736 DOI: 10.3389/fmed.2021.714619] [Reference Citation Analysis]
2 Liu XS, Yuan LL, Gao Y, Zhou LM, Yang JW, Pei ZJ. Overexpression of METTL3 associated with the metabolic status on 18F-FDG PET/CT in patients with Esophageal Carcinoma. J Cancer 2020;11:4851-60. [PMID: 32626532 DOI: 10.7150/jca.44754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]